Compare ADIL & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADIL | NCPL |
|---|---|---|
| Founded | 2010 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.9M |
| IPO Year | 2017 | N/A |
| Metric | ADIL | NCPL |
|---|---|---|
| Price | $1.89 | $0.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $37.50 | N/A |
| AVG Volume (30 Days) | 95.4K | ★ 129.8K |
| Earning Date | 03-06-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $739.37 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.37 |
| 52 Week High | $3.67 | $8.75 |
| Indicator | ADIL | NCPL |
|---|---|---|
| Relative Strength Index (RSI) | 49.67 | 40.36 |
| Support Level | $0.28 | $0.37 |
| Resistance Level | $3.67 | $0.58 |
| Average True Range (ATR) | 0.20 | 0.05 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 45.95 | 22.73 |
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.